Peptide Schedule
Pinealon3 residuesEDREach bubble = one amino acid. Size = residue mass. Color = chemical class.

Pinealon Dosage Calculator

CognitiveInjection/OralResearch~15-30 minutes half-life

Pinealon is a synthetic tripeptide bioregulator composed of L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg, or EDR).

May support neuroprotection via reduced neuronal apoptosis (preclinical data)Proposed improvement in sleep onset and circadian rhythm regulationPotential enhancement of memory and focus in aging populationsIncreased neuronal spine density observed in Alzheimer's disease cell models4 weeks on / 8 weeks off

50mcg · Daily

100500
0.5 units
100 units (1mL)
Concentration
10,000
mcg/mL
Draw Volume
0.005
mL
Syringe Units
0.5
units
Doses / Vial
400
doses
Very small draw (0.5 units) — difficult to measure accurately. Consider using less BAC water for a more concentrated solution.
Try 0.5mL BAC water for an easier-to-measure draw.

Summary: Add 2mL BAC water to your 20mg vial. Draw to 0.5 units on a U-100 syringe for a 50mcg dose. This vial will last 400 doses.

Cycle Planner

Subcutaneous or Oral. Typical beginner frequency: daily.

Pinealon Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = ~15-30 minutes (estimated)
50%25%12.5%100%75%50%25%0%023m45m1h2h2hTime after injectionDose remaining
After 1 half-life (23m): 50% remainsAfter 2 half-lives (45m): 25% remainsAfter 3 half-lives (1h): 12.5% remains
At a 100mcg dose: 50% = 50mcg remaining after 23m. Recommended frequency: Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Pinealon Dosing Protocol

LevelDose / InjectionFrequency
Beginner50mcgDaily
Moderate100mcgDaily
Aggressive200mcgDaily

Note: Tripeptide bioregulator (Glu-Asp-Arg). Targets pineal gland and CNS. Dose in the evening. Oral capsules also available. Very limited human PK data — dosing based on Russian bioregulator protocols.

About Pinealon

Pinealon is a synthetic tripeptide bioregulator composed of L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg, or EDR). Developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it belongs to the cytomedins — short peptides derived from tissue-specific extracts. Pinealon is proposed to target the pineal gland and central nervous system, with preclinical studies suggesting it may cross the blood-brain barrier and interact directly with chromatin to influence gene expression. Animal and in vitro research has linked EDR to increased neuronal viability, reduced apoptosis, and modulation of BDNF and antioxidant pathways. However, the evidence base is narrow: most studies originate from a single research group, many are published only in Russian, and no controlled human clinical trials have been completed. Claims around sleep quality, circadian rhythm correction, and cognitive enhancement remain preliminary. Users should treat Pinealon as an experimental compound with significant evidence gaps.

Frequently Asked Questions